wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38498207-0074E6D9-D0D0-4FBD-BFA0-BE28FF9800C9
Q38498207-0074E6D9-D0D0-4FBD-BFA0-BE28FF9800C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38498207-0074E6D9-D0D0-4FBD-BFA0-BE28FF9800C9
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
P2860
Q38498207-0074E6D9-D0D0-4FBD-BFA0-BE28FF9800C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38498207-0074E6D9-D0D0-4FBD-BFA0-BE28FF9800C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55fbb88a56cafc70e471d100721a22d93df06e1e
P2860
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.